Safety and Efficacy of Locoregional Treatment during Immunotherapy with Nivolumab for Hepatocellular Carcinoma: A Retrospective Study of 41 Interventions in 29 Patients.
J Vasc Interv Radiol
; 31(11): 1729-1738.e1, 2020 Nov.
Article
in En
| MEDLINE
| ID: mdl-33012649
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Hepatocellular
/
Embolization, Therapeutic
/
Antineoplastic Agents, Immunological
/
Nivolumab
/
Liver Neoplasms
Type of study:
Observational_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
J Vasc Interv Radiol
Journal subject:
ANGIOLOGIA
/
RADIOLOGIA
Year:
2020
Document type:
Article
Country of publication: